METTL3 serves as a central methyltransferase within the N6-methyladenosine (m6A) modification system [16], functioning as the m6A “writer” implicated in both the initiation and maintenance of AML [17, 18]. The gene discussed is METTL3; the disease is acute myeloid leukemia.